Sector archive

Published briefings for one sector.

Browse recent results from companies in the same sector.

All briefings Consumer Healthcare Transport & Infrastructure Primary Industries Property Investment Companies Technology Construction & Materials

Search company archive

Open archive

Company archive

Sector archive

Clear filters

Showing 49-72 of 81 published briefings.

EBOS Group (EBO)HY24Released 21 February 2024

OCF fell 34.5% and leverage rose to 1.8x as inventories built $140m

EBITDA rose 4.8% but operating cash fell 34.5% on a $140.3m inventory build, leaving the lifted 57.0c dividend uncovered by free cash flow.

Published 22 April 2026

Read briefing

Ryman Healthcare (RYM)HY24Released 29 November 2023

Dividend suspended as FCF stays $158.4m negative, PBT falls 34%

Headline NPAT declines just 3.8% on a 30.2% tax credit, but underlying profit is flat and pre-lease cash flow sits well below the historical range.

Published 28 April 2026

Read briefing

Green Cross Health (GXH)HY24Released 29 November 2023

Pharmacy EBIT fell 25% as COVID tail faded; net cash flipped to net debt

The 29.5% headline revenue drop reflects the Community Health divestment, but continuing operations show eroding margins and a balance sheet that no

Published 22 April 2026

Read briefing

Fisher & Paykel Healthcare (FPH)HY24Released 29 November 2023

Capex doubled to 34.3% of revenue, pre-lease FCF swung to NZ$127.5m negative

Revenue grew 16.4% and PBT 23.0%, but a doubled capex bill drove pre-lease FCF NZ$258.5m below the historical mean and left the dividend uncovered.

Published 22 April 2026

Read briefing

Promisia Healthcare (PHL)HY24Released 28 November 2023

Revenue up 10.7% but PBT swung to a NZ$0.1m loss as costs outpaced growth

Promisia's aged-care operations grew the top line solidly, but earnings turned negative as cost growth absorbed the revenue gain, leaving a NPAT loss

Published 19 May 2026

Read briefing

Radius Residential Care (RAD)HY24Released 27 November 2023

Asset sale puts Radius Residential Care's debt headroom in focus

The NZ$19m disclosed value from the asset sale is relevant to debt headroom, while borrowings and gearing remain the direct evidence.

Published 23 April 2026

Read briefing

Oceania Healthcare (OCA)HY24Released 22 November 2023

NPAT swung to NZ$35.2m but trade debtors expanded NZ$110.5m

Underlying EBITDA held near NZ$37.6m, but receivables expanded NZ$110.5m and debtor days hit 168.5 against a historical mean of 22.7 days.

Published 22 April 2026

Read briefing

Blis Technologies (BLT)HY24Released 16 November 2023

Loss narrowed 60.3% but operating cash turned negative as debtors swelled

Revenue grew 11.4% yet receivables almost doubled and debtor days hit 37.9, well above the historical mean of 28.7.

Published 22 April 2026

Read briefing

Rua Bioscience (RUA)FY23Released 29 August 2023

Customer revenue $0.4m as cash burn $5.9m leaves $2.5m on hand

Headline revenue of $6.5m is dominated by fair value gains on contingent consideration; commercial revenue remains immaterial against ongoing burn.

Published 23 April 2026

Read briefing

Summerset Group Holdings (SUM)HY23Released 23 August 2023

Operating cash fell 23% and borrowings rose 47% on heavier development

Underlying profit lifted 5.7% to $87.2m but reported NPAT slipped 1.1% as fair-value gains shrank and capex climbed 24.9%.

Published 23 April 2026

Read briefing

Promisia Healthcare (PHL)FY23Released 30 May 2023

PBT fell 73.7% as revenue growth failed to offset cost expansion

A 25.5% revenue uplift was more than consumed by higher operating costs, lifting net debt to EBITDA to 8.0x and compressing PBT to NZ$0.5m.

Published 18 May 2026

Read briefing

Green Cross Health (GXH)FY23Released 30 May 2023

NPAT up 83.7% on $30.3m disposal gain as continuing PBT fell 43.5%

The discontinued operation supplied two-thirds of reported NPAT while operating cash flow fell 30.3% and continuing EBIT dropped 29%.

Published 22 April 2026

Read briefing

Radius Residential Care (RAD)FY23Released 29 May 2023

H2 EBITDA collapsed to $2.9m as net debt tripled to $100.1m

Debt-funded property purchases pushed leverage to 7.0x EBITDA while operating cash flow fell 59% and the result swung to a $2.1m loss.

Published 22 April 2026

Read briefing

Third Age Health Services (TAH)FY23Released 26 May 2023

Revenue nearly doubled but PBT fell 56% as costs outpaced growth

Effective tax rate jumped from 24.9% to 43.5%, deepening the NPAT decline to 67% while operating cash flow held essentially flat at $1.1m.

Published 28 April 2026

Read briefing

Fisher & Paykel Healthcare (FPH)FY23Released 26 May 2023

FY23 FCF collapsed to $12.5m as capex stepped up 53%

H2 revenue rebounded 14%, but a 40.5c full-year dividend ran well past FCF cover with capex intensity climbing to 13.4% of revenue.

Published 22 April 2026

Read briefing

Blis Technologies (BLT)FY23Released 25 May 2023

Loss narrowed 50.1% on 14.2% revenue growth, cash halved to $4.3m

Operating cash flow flipped positive and H2 turned profitable, yet the cash balance fell $4.2m versus only $0.1m of OCF — a reconciliation gap that

Published 22 April 2026

Read briefing

Oceania Healthcare (OCA)FY23Released 24 May 2023

Net debt/EBITDA jumped to 6.9x as operating cash fell 33%

Revenue grew 6.9% and care swung to profit, but borrowings rose $177.9m and a $86.9m receivables build absorbed underlying cash generation.

Published 22 April 2026

Read briefing

Rua Bioscience (RUA)HY23Released 28 February 2023

Reported $0.7m profit masks unchanged $3.7m cash burn against $1.7m balance

Non-cash items drove the swing to NPAT while operating cash outflow held near prior levels and the cash balance fell 24.5%.

Published 23 April 2026

Read briefing

Summerset Group Holdings (SUM)FY22Released 24 February 2023

Underlying profit up 21.5% while IFRS NPAT fell 50.5% on revaluation

Development capex of $633.8m pushed gross borrowings to $1.07b and free cash flow to -$14.7m, with operating cash flow still near prior-year levels.

Published 22 April 2026

Read briefing

Truscreen Group (TRU)HY23Released 29 November 2022

Cash down to $1.7m as $1.2m HY operating burn continues

Operating cash outflow narrowed 29.3% to $1.2m, but at $0.74m half-year revenue, runway is now the central question.

Published 28 April 2026

Read briefing

Fisher & Paykel Healthcare (FPH)HY23Released 29 November 2022

Working capital absorbed NZ$58.7m, draining operating cash to NZ$1.9m

Revenue fell 23.3% on post-COVID normalisation, but a NZ$58.7m working-capital build left the lifted dividend uncovered by free cash flow.

Published 22 April 2026

Read briefing

Third Age Health Services (TAH)HY23Released 28 November 2022

Acquisition lifted revenue 61.2% but continuing NPAT fell 51.8%

Integration and consolidation costs for acquired GP practices absorbed the acquired revenue and roughly halved earnings to $0.3m.

Published 22 April 2026

Read briefing

Green Cross Health (GXH)HY23Released 25 November 2022

PBT up 20.3% on Medical and Community gains, pharmacy result fell 13%

The dominant pharmacy segment lost revenue share and earnings while a 30.3% effective tax rate clipped NPAT growth to 17.5%.

Published 22 April 2026

Read briefing

Ryman Healthcare (RYM)HY23Released 18 November 2022

NZ$281m working-capital build cut pre-lease FCF to NZ$51.8m as NPAT fell 31%

Underlying profit rose 44.8% but reported NPAT fell 31.1% as receivables expanded and capex jumped 56%, draining cash flow despite revenue growth.

Published 28 April 2026

Read briefing

Get reporting-season briefings

Get full NZX result briefings by email as new coverage is published.